Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

CABG surgery versus drug-eluting stent implantation in multivessel disease: a cardiovascular surgeon's perspective

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 450–451 (2008)Cite this article

Hannan EL et al. (2008) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358: 331–341

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Taggart DP (2006) Thomas B Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 82: 1966–1975

    Article  Google Scholar 

  2. Taggart DP (2007) Coronary artery bypass graft vs percutaneous coronary angioplasty: CABG on the rebound? Curr Opin Cardiol 22: 517–523

    Article  Google Scholar 

  3. Hannan EL et al. (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352: 2174–2183

    Article  CAS  Google Scholar 

  4. Hannan EL et al. (2006) Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 113: 2406–2412

    Article  Google Scholar 

  5. Hill RA et al. (2007) Drug-eluting stents: a systematic review and economic evaluation. Health Technol Assess 11: iii, xi–221

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Cardiac Surgery, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK david.taggart@orh.nhs.uk

Authors and Affiliations

  1. DP Taggart is Professor of Cardiovascular Surgery at the University of Oxford and a Consultant Cardiac Surgeon at the John Radcliffe Hospital, Oxford, UK.,

    David P Taggart

Authors
  1. David P Taggart
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taggart, D. CABG surgery versus drug-eluting stent implantation in multivessel disease: a cardiovascular surgeon's perspective. Nat Rev Cardiol 5, 450–451 (2008). https://doi.org/10.1038/ncpcardio1274

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1274

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing